Skip to main content

Advertisement

SpringerLink
Log in

IAP perspectives on measles and rubella elimination strategies

  • Position Paper
  • Published:
Indian Pediatrics Aims and scope Submit manuscript

Abstract

The Academy’s Expert group on Immunization has discussed various issues pertaining to rubella vaccine introduction in to the Universal Immunization Program. Though the move to introduce rubella vaccine in to the UIP is laudable, the decision to overlook mumps seems inexplicable and illogical. Logistics also support the use of measles-mump and rubella (MMR) vaccine instead of measles-rubella (MR) vaccine. Regarding the timing of administration of MMR/MR vaccine, the academy recommends that the vaccine should be given early to have much higher coverage than introducing it late at the time of 1st booster of DPT. According to available evidence, both these vaccines (MMR/MR) can be given safely at different ages including at 9 months of age. The second dose should also be of the same antigen (MMR/MR) and be given along with 1st DPT booster at 16–24 months of age.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Government of India, Ministry of Health and Family Welfare (Immunization Division). ICMR Expert Group Recommendations on inclusion of Rubella vaccination, ICMR, May, 2012.

  2. Dewan P, Gupta P. Burden of congenital rubella syndrome (CRS) in India: A systematic review. Indian Pediatr. 2012;49:377–99.

    Article  PubMed  Google Scholar 

  3. John TJ. An outbreak of mumps in Thiruvananthapuram district. Indian Pediatr. 2004;41:298–300.

    PubMed  Google Scholar 

  4. Geeta MG, Kumar PK. Mumps — need for urgent action. Indian Pediatr 2004;41:1181–2.

    PubMed  CAS  Google Scholar 

  5. Ghatage ST, Kakade GM. An outbreak of mumps meningoencephalitis in Sangli district. Indian Pediatr. 2007;44:235.

    PubMed  CAS  Google Scholar 

  6. Jeevan M, Sambantham S, Thangam M. Characterisation of mumps virus genotype C among patients with mumps in India. Indian J Med Microbiol. 2013;31:290–2.

    Article  PubMed  CAS  Google Scholar 

  7. Mishra B, Pujhari SK, Dhiman V, Mahalakshmi P, Bharadwaj A, Pokhrel S, et al. Genotyping and subtyping of mumps virus isolates from the Indian subcontinent. Arch Virol. 2013;158:2359–63.

    Article  PubMed  CAS  Google Scholar 

  8. Vaidya SR, Chowdhury DT, Kumbhar NS, Tomar R, Kamble MB, Kazi MI. Circulation of two mumps virus genotypes in an unimmunized population in India. J Med Virol. 2013;85:1426–32.

    Article  PubMed  CAS  Google Scholar 

  9. IDsurv. Infectious Disease Surveillance Project. Available from: www.idsurv.org

  10. WHO Position Paper, Mumps Virus Vaccines. Wkly Epidemiol Rec. 2007;82:49–60.

    Google Scholar 

  11. Wang W, Zhu Y, Wu H, Jiao Y, Van Halm-Lutterodt N, Li W. IL-6 and IFNa are elevated in severe mumps cases: A study of 960 mumps patients in China. J Infect Dev Ctries. 2014;8:208–14.

    PubMed  CAS  Google Scholar 

  12. Background material for NTAGI Standing Technical Sub-Committee (STSC) Meeting on “Potential Strategies for the Control of Rubella and CRS Burden in India.” February 26, 2014; Indian Council of Medical Research, New Delhi.

  13. Status Report on Progress towards Measles and Rubella Elimination. SAGE Working Group on Measles and Rubella (17 October 2013) Available from: http://www.who.int/immunization/sage/meetings/2013/november/Status_Report_Measles_Rubella21Oct2013_FINAL.pdf Accessed on May 19, 2014.

  14. Measles, Mumps and Rubella Vaccines. In: Vashishtha VM, Choudhury P, Bansal CP, Yewale VN, Agarwal R. editors. IAP Guidebook on Immunization 2013–2014. National Publication House, Indian Academy of Pediatrics, Gwalior, 2014.

  15. Schoub BD, Johnson S, McAnerney JM, Wagstaff LA, Matsie W, Reinach SG, et al. Measles, mumps, and rubella immunization at nine months in a developing country. Pediatr Infect Dis J. 1990; 9:263–7.

    Article  PubMed  CAS  Google Scholar 

  16. Giammanco G, Li Volti S, Salemi I, Giammanco Bilancia G, Mauro L. Immune response to simultaneous administration of a combined measles, mumps and rubella vaccine with booster doses of diphtheria-tetanus and poliovirus vaccine. Eur J Epidemiol. 1993; 9:199–202.

    Article  PubMed  CAS  Google Scholar 

  17. Singh R, John TJ, Cherian T, Raghupathy P. Immune response to measles, mumps and rubella vaccine at 9, 12 and 15 months of age. Indian J Med Res. 1994;100:155–9.

    PubMed  CAS  Google Scholar 

  18. Forleo-Neto E, Carvalho ES, Fuentes IC, Precivale MS, Forleo LH, Farhat CK. Seroconversion of a trivalent measles, mumps, and rubella vaccine in children aged 9, 12 and 15 months. Vaccine. 1997;15:1898–901.

    Article  PubMed  CAS  Google Scholar 

  19. Klinge J, Lugauer S, Korn K, Heininger U, Stehr K. Comparison of immunogenicity and reactogenicity of a measles, mumps and rubella (MMR) vaccine in German children vaccinated at 9–11, 12–14 or 15–17 months of age. Vaccine. 2000;18:3134–40.

    Article  PubMed  CAS  Google Scholar 

  20. Yadav S, Thukral R, Chakarvarti A. Comparative evaluation of measles, mumps & rubella vaccine at 9 & 15 months of age. Indian J Med Res. 2003;118:183–6.

    PubMed  Google Scholar 

  21. Goh P, Lim FS, Han HH, Willems P. Safety and immunogenicity of early vaccination with two doses of tetravalent measles-mumps-rubella (MMRV) vaccine in healthy children from 9 months of age. Infection 2007;35:326–33.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Advisory Committee on Vaccines and Immunization Practices (ACVIP), Indian Academy of Pediatrics, Bijnor, India

    Vipin M. Vashishtha, Vijay N. Yewale, C. P. Bansal & Pravin J. Mehta

Authors
  1. Vipin M. Vashishtha
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vijay N. Yewale
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. P. Bansal
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pravin J. Mehta
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vipin M. Vashishtha.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vashishtha, V.M., Yewale, V.N., Bansal, C.P. et al. IAP perspectives on measles and rubella elimination strategies. Indian Pediatr 51, 719–722 (2014). https://doi.org/10.1007/s13312-014-0488-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13312-014-0488-7

Keywords

Search

Navigation